196 related articles for article (PubMed ID: 19640729)
1. Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.
Chérel M; Campion L; Bézieau S; Campone M; Charrier J; Gaschet J; Ricolleau G; Gouraud W; Charbonnel C; Jézéquel P
Cytokine; 2009 Sep; 47(3):214-23. PubMed ID: 19640729
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
Litovkin KV; Domenyuk VP; Bubnov VV; Zaporozhan VN
Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
[TBL] [Abstract][Full Text] [Related]
4. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
Smith KC; Bateman AC; Fussell HM; Howell WM
Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
[TBL] [Abstract][Full Text] [Related]
7. [Association between polymorphisms of interleukin-6 gene promoter and breast cancer].
He KL; Li YP; Lv YG; Zhang DJ; Wang H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1220-2. PubMed ID: 22078452
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
[TBL] [Abstract][Full Text] [Related]
9. A common interleukin-6 promoter polymorphism in patients with vulvar cancer.
Grimm C; Six L; Tomovski C; Speiser P; Joura E; Zeillinger R; Sliutz G; Reinthaller A; Hefler LA
J Soc Gynecol Investig; 2005 Dec; 12(8):617-20. PubMed ID: 16198606
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 -174G/C polymorphism and longevity: a follow-up study.
Hurme M; Lehtimäki T; Jylhä M; Karhunen PJ; Hervonen A
Mech Ageing Dev; 2005 Mar; 126(3):417-8. PubMed ID: 15664628
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm.
Smallwood L; Allcock R; van Bockxmeer F; Warrington N; Palmer LJ; Iacopetta B; Norman PE
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):31-6. PubMed ID: 17996468
[TBL] [Abstract][Full Text] [Related]
12. Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Clin Immunol; 2008 Aug; 128(2):199-204. PubMed ID: 18502691
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma.
Snoussi K; Mahfoudh W; Bouaouina N; Ahmed SB; Helal AN; Chouchane L
Hum Immunol; 2006; 67(1-2):13-21. PubMed ID: 16698420
[TBL] [Abstract][Full Text] [Related]
14. The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality.
Berger FG
Breast Cancer Res Treat; 2004 Dec; 88(3):281-5. PubMed ID: 15609131
[TBL] [Abstract][Full Text] [Related]
15. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
Varadi V; Brendle A; Grzybowska E; Johansson R; Enquist K; Butkiewicz D; Pamula-Pilat J; Pekala W; Hemminki K; Lenner P; Försti A
Cancer Genet Cytogenet; 2009 Apr; 190(2):71-4. PubMed ID: 19380022
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
Tan D; Wu X; Hou M; Lee SO; Lou W; Wang J; Janarthan B; Nallapareddy S; Trump DL; Gao AC
J Urol; 2005 Aug; 174(2):753-6. PubMed ID: 16006970
[TBL] [Abstract][Full Text] [Related]
17. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.
Decock J; Long JR; Laxton RC; Shu XO; Hodgkinson C; Hendrickx W; Pearce EG; Gao YT; Pereira AC; Paridaens R; Zheng W; Ye S
Cancer Res; 2007 Nov; 67(21):10214-21. PubMed ID: 17974962
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer.
Apaydin I; Konac E; Onen HI; Akbaba M; Tekin E; Ekmekci A
Arch Med Res; 2008 Apr; 39(3):338-45. PubMed ID: 18279708
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between IL-6-174G/C gene polymorphism and Chagas disease.
Torres OA; Calzada JE; Beraún Y; Morillo CA; González A; González CI; Martín J
Tissue Antigens; 2010 Aug; 76(2):131-4. PubMed ID: 20331841
[TBL] [Abstract][Full Text] [Related]
20. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer.
Belluco C; Olivieri F; Bonafè M; Giovagnetti S; Mammano E; Scalerta R; Ambrosi A; Franceschi C; Nitti D; Lise M
Clin Cancer Res; 2003 Jun; 9(6):2173-6. PubMed ID: 12796383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
